Luca Cancanelli

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Topics

Acute Lymphoblastic Leukemia

Multiple Myeloma

Top Venues

Hematology reports

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori
Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments. Hematology reports 15 (1) (2023)
Andrea Messori, Vera Damuzzo, Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Andrea Ossato, Marco Chiumente, Daniele Mengato
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses. Cancers 15 (6) (2023)
Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori
Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments. Hematology reports 15 (1) (2023)
Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori
Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments. Hematology reports 15 (1) (2023)
Andrea Messori, Vera Damuzzo, Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Andrea Ossato, Marco Chiumente, Daniele Mengato
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses. Cancers 15 (6) (2023)
Daniele Mengato, Luca Cancanelli, Melania Rivano, Marco Chiumente, Lorenzo Di Spazio, Andrea Messori
First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancer. Immunotherapy 14 (11) (2022)
Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Daniele Mengato, Marco Chiumente, Andrea Messori
Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials. World journal of urology 40 (11) (2022)
Vera Damuzzo, Laura Agnoletto, Roberta Rampazzo, Francesca Cammalleri, Luca Cancanelli, Marco Chiumente, Stefano Costantino, Silvia Michielan, Federica Milani, Alessia Sartori, Melania Rivano, Daniele Mengato
The QOSMOS Study: Pharmacist-Led Multicentered Observational Study on Quality of Life in Multiple Sclerosis. Neurology international 13 (4) (2021)
Andrea Messori, Melania Rivano, Daniele Mengato, Luca Cancanelli, Lorenzo Di Spazio, Marco Chiumente
A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia. Leukemia & lymphoma 63 (5) (2021)
Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori
Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: analysis of 4 clinical studies. Immunotherapy 13 (2) (2020)
Melania Rivano, Luca Cancanelli, Andrea Zovi, Chiara Addis, Daniele Mengato, Marco Chiumente, Andrea Messori
Tyrosine-kinase inhibitor discontinuation in chronic myeloid leukaemia after deep molecular response: a meta-analysis with meta-regression. Journal of chemotherapy (Florence, Italy) 32 (5) (2020)